Cure My Disease

Don't miss your cure!

 Log in / Sign up

Blood test may catch pelvic cancer relapse sooner

NCT ID NCT03739775

Completed Diagnosis Sponsor: Institut Curie Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jul 08, 2026 · Updated 2 times

Summary

This study looks at whether a blood test that detects tumor DNA can find early signs of cancer returning in people treated for HPV-positive pelvic cancers (like cervical or anal cancer). Researchers will take blood samples from 172 patients during regular follow-up visits. The goal is to see how well this test works at spotting relapses before symptoms appear.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this blood test could help catch cancer relapses earlier, potentially improving treatment outcomes.
What could go wrong
This is an observational study, not a treatment trial. The test may not be accurate enough for routine use, and results may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HPV POSITIVE PELVIC CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

anal canal cancer anal canal squamous cell carcinoma cervical carcinoma human papillomavirus-related penile squamous cell carcinoma penile cancer vaginal cancer vaginal carcinoma vulva cancer vulvar carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HPV POSITIVE PELVIC CANCER

Contacts and locations

Locations

  • CHU Pontchaillou

    Rennes, 35033, France

  • CHU de Besançon

    Besançon, 25030, France

  • Hôpital Tenon

    Paris, 75020, France

  • Institut Curie - Paris

    Paris, 75005, France

  • Institut Curie - Saint-Cloud

    Saint-Cloud, 92210, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.